B3-500-Gr Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with B3-500-Gr
H
- Habitrol (nicotine)
- Halfprin (aspirin)
- Heartline (aspirin)
- Helidac (bismuth subsalicylate / metronidazole / tetracycline)
- Humalog (insulin lispro)
- Humalog Junior KwikPen (insulin lispro)
- Humalog KwikPen (insulin lispro)
- Humalog Mix 50/50 (insulin lispro/insulin lispro protamine)
- Humalog Mix 50/50 KwikPen (insulin lispro/insulin lispro protamine)
- Humalog Mix 75/25 (insulin lispro/insulin lispro protamine)
- Humalog Mix 75/25 KwikPen (insulin lispro/insulin lispro protamine)
- Humulin 50 / 50 (insulin isophane / insulin regular)
- Humulin 70 / 30 (insulin isophane / insulin regular)
- Humulin 70 / 30 Pen (insulin isophane / insulin regular)
- Humulin L (insulin zinc)
- Humulin N (insulin isophane)
- Humulin N Pen (insulin isophane)
- Humulin R (insulin regular)
- Humulin R U-500 (Concentrated) (insulin regular)
- Humulin R U-500 KwikPen (insulin regular)
- Humulin U (insulin zinc extended)
- Hyolev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Hyophen (benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- hyoscyamine / methenamine / methylene blue / phenyl salicylate
- hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate
More about B3-500-Gr (niacin)
- B3-500-Gr consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.